Ulcerative Colitis Treatment Market Key Players and Industry Insights
FAQ's
Answer : According to Precedence Research, the targeted therapeutics market size was reached at USD 67 billion in 2021 and is projected to hit USD 128 billion by 2030.
Answer : The growing burden of critical diseases such as cancer, leukemia, lymphoma, and muscular degeneration are the major factors that boost the adoption of targeted therapeutics among the global population.
Answer : The global targeted therapeutics market is expected to grow at a CAGR 2.4% during the forecast period 2021 to 2030.
Answer : The major players in the targeted therapeutics market are Pfizer, Inc., AstraZeneca Plc., Amgen, Inc., F. Hoffmann-La Roche & Co., Genentech, Inc., Agenus, Inc., Celdara Medical LLC, Arcus Biosciences, Inc., Aurinia Pharmaceuticals Inc., Gilead Sciences, Inc., Serena Therapeutics Inc., Nektar Therapeutics Inc..
Answer : The North America will lead the global targeted therapeutics market during the forecast period 2021 to 2030.
Get a Sample of this Report
Ulcerative Colitis Treatment Market
